Practice Parameter: neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
Identifieur interne : 002719 ( Main/Exploration ); précédent : 002718; suivant : 002720Practice Parameter: neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
Auteurs : O. Suchowersky [Canada] ; G. Gronseth ; J. Perlmutter ; S. Reich ; T. Zesiewicz ; W J WeinerSource :
- Neurology [ 1526-632X ] ; 2006.
Descripteurs français
- Wicri :
- geographic : États-Unis.
English descriptors
- KwdEn :
- MESH :
- chemical , therapeutic use : Levodopa.
- geographic : United States.
- drug therapy : Parkinson Disease.
- physiopathology : Parkinson Disease.
- standards : Complementary Therapies, Neurology.
- therapy : Parkinson Disease.
- Accidental Falls, Humans, Quality Assurance, Health Care.
Abstract
To define key issues in the management of Parkinson disease (PD) relating to neuroprotective strategies and alternative treatments, and to make evidence-based treatment recommendations.
DOI: 10.1212/01.wnl.0000206363.57955.1b
PubMed: 16606908
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001175
- to stream PubMed, to step Curation: 001175
- to stream PubMed, to step Checkpoint: 001175
- to stream Ncbi, to step Merge: 000637
- to stream Ncbi, to step Curation: 000637
- to stream Ncbi, to step Checkpoint: 000637
- to stream Main, to step Merge: 002995
- to stream Main, to step Curation: 002719
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Practice Parameter: neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.</title><author><name sortKey="Suchowersky, O" sort="Suchowersky, O" uniqKey="Suchowersky O" first="O" last="Suchowersky">O. Suchowersky</name><affiliation wicri:level="4"><nlm:affiliation>University of Calgary, Calgary, AB, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>University of Calgary, Calgary, AB</wicri:regionArea><orgName type="university">Université de Calgary</orgName><placeName><settlement type="city">Calgary</settlement><region type="state">Alberta</region></placeName></affiliation></author><author><name sortKey="Gronseth, G" sort="Gronseth, G" uniqKey="Gronseth G" first="G" last="Gronseth">G. Gronseth</name></author><author><name sortKey="Perlmutter, J" sort="Perlmutter, J" uniqKey="Perlmutter J" first="J" last="Perlmutter">J. Perlmutter</name></author><author><name sortKey="Reich, S" sort="Reich, S" uniqKey="Reich S" first="S" last="Reich">S. Reich</name></author><author><name sortKey="Zesiewicz, T" sort="Zesiewicz, T" uniqKey="Zesiewicz T" first="T" last="Zesiewicz">T. Zesiewicz</name></author><author><name sortKey="Weiner, W J" sort="Weiner, W J" uniqKey="Weiner W" first="W J" last="Weiner">W J Weiner</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2006">2006</date><idno type="RBID">pubmed:16606908</idno><idno type="pmid">16606908</idno><idno type="doi">10.1212/01.wnl.0000206363.57955.1b</idno><idno type="wicri:Area/PubMed/Corpus">001175</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001175</idno><idno type="wicri:Area/PubMed/Curation">001175</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001175</idno><idno type="wicri:Area/PubMed/Checkpoint">001175</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001175</idno><idno type="wicri:Area/Ncbi/Merge">000637</idno><idno type="wicri:Area/Ncbi/Curation">000637</idno><idno type="wicri:Area/Ncbi/Checkpoint">000637</idno><idno type="wicri:Area/Main/Merge">002995</idno><idno type="wicri:Area/Main/Curation">002719</idno><idno type="wicri:Area/Main/Exploration">002719</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Practice Parameter: neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.</title><author><name sortKey="Suchowersky, O" sort="Suchowersky, O" uniqKey="Suchowersky O" first="O" last="Suchowersky">O. Suchowersky</name><affiliation wicri:level="4"><nlm:affiliation>University of Calgary, Calgary, AB, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>University of Calgary, Calgary, AB</wicri:regionArea><orgName type="university">Université de Calgary</orgName><placeName><settlement type="city">Calgary</settlement><region type="state">Alberta</region></placeName></affiliation></author><author><name sortKey="Gronseth, G" sort="Gronseth, G" uniqKey="Gronseth G" first="G" last="Gronseth">G. Gronseth</name></author><author><name sortKey="Perlmutter, J" sort="Perlmutter, J" uniqKey="Perlmutter J" first="J" last="Perlmutter">J. Perlmutter</name></author><author><name sortKey="Reich, S" sort="Reich, S" uniqKey="Reich S" first="S" last="Reich">S. Reich</name></author><author><name sortKey="Zesiewicz, T" sort="Zesiewicz, T" uniqKey="Zesiewicz T" first="T" last="Zesiewicz">T. Zesiewicz</name></author><author><name sortKey="Weiner, W J" sort="Weiner, W J" uniqKey="Weiner W" first="W J" last="Weiner">W J Weiner</name></author></analytic><series><title level="j">Neurology</title><idno type="eISSN">1526-632X</idno><imprint><date when="2006" type="published">2006</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Accidental Falls</term><term>Complementary Therapies (standards)</term><term>Humans</term><term>Levodopa (therapeutic use)</term><term>Neurology (standards)</term><term>Parkinson Disease (drug therapy)</term><term>Parkinson Disease (physiopathology)</term><term>Parkinson Disease (therapy)</term><term>Quality Assurance, Health Care</term><term>United States</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Levodopa</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>United States</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="standards" xml:lang="en"><term>Complementary Therapies</term><term>Neurology</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Accidental Falls</term><term>Humans</term><term>Quality Assurance, Health Care</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>États-Unis</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">To define key issues in the management of Parkinson disease (PD) relating to neuroprotective strategies and alternative treatments, and to make evidence-based treatment recommendations.</div></front></TEI><affiliations><list><country><li>Canada</li></country><region><li>Alberta</li></region><settlement><li>Calgary</li></settlement><orgName><li>Université de Calgary</li></orgName></list><tree><noCountry><name sortKey="Gronseth, G" sort="Gronseth, G" uniqKey="Gronseth G" first="G" last="Gronseth">G. Gronseth</name><name sortKey="Perlmutter, J" sort="Perlmutter, J" uniqKey="Perlmutter J" first="J" last="Perlmutter">J. Perlmutter</name><name sortKey="Reich, S" sort="Reich, S" uniqKey="Reich S" first="S" last="Reich">S. Reich</name><name sortKey="Weiner, W J" sort="Weiner, W J" uniqKey="Weiner W" first="W J" last="Weiner">W J Weiner</name><name sortKey="Zesiewicz, T" sort="Zesiewicz, T" uniqKey="Zesiewicz T" first="T" last="Zesiewicz">T. Zesiewicz</name></noCountry><country name="Canada"><region name="Alberta"><name sortKey="Suchowersky, O" sort="Suchowersky, O" uniqKey="Suchowersky O" first="O" last="Suchowersky">O. Suchowersky</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002719 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002719 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:16606908
|texte= Practice Parameter: neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:16606908" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a ParkinsonCanadaV1
| This area was generated with Dilib version V0.6.29. |  |